Regarding this aspect, Velasco-Velazquez and Pestell [74] used preclinical models and demonstrated that CCR5 promotes basal breast cancer subtype invasiveness and metastatic potential, while CCR5 inhibition abrogates them [75]. Here, CCR5 is linked to breast cancer.